REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 28 filers reported holding REVANCE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,229,880 | -23.3% | 4,000,000 | 0.0% | 0.02% | -19.0% |
| Q2 2023 | $4,213,720 | -14.7% | 4,000,000 | 0.0% | 0.02% | -12.5% |
| Q1 2023 | $4,941,000 | +33.0% | 4,000,000 | 0.0% | 0.02% | +41.2% |
| Q4 2022 | $3,714,640 | -14.0% | 4,000,000 | 0.0% | 0.02% | -15.0% |
| Q3 2022 | $4,317,000 | +29.2% | 4,000,000 | 0.0% | 0.02% | +42.9% |
| Q2 2022 | $3,342,000 | -11.2% | 4,000,000 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $3,765,000 | +5.2% | 4,000,000 | 0.0% | 0.01% | +7.7% |
| Q4 2021 | $3,578,000 | -22.0% | 4,000,000 | 0.0% | 0.01% | -35.0% |
| Q3 2021 | $4,585,000 | -2.0% | 4,000,000 | 0.0% | 0.02% | -4.8% |
| Q2 2021 | $4,680,000 | +3.4% | 4,000,000 | 0.0% | 0.02% | -16.0% |
| Q1 2021 | $4,526,000 | – | 4,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 20,087 | $23,535,000 | 2.18% |
| ZAZOVE ASSOCIATES LLC | 15,910,000 | $18,551,000 | 1.66% |
| SSI INVESTMENT MANAGEMENT LLC | 4,487,000 | $5,231,000 | 0.34% |
| DeepCurrents Investment Group LLC | 4,918,000 | $5,752,000 | 0.17% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 3,000,000 | $3,500,000 | 0.05% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 12,500,000 | $14,646,000 | 0.03% |
| Citadel Advisors | 104,329,000 | $122,081,000 | 0.03% |
| LAZARD ASSET MANAGEMENT LLC | 20,000,000 | $23,433,000 | 0.03% |
| WOLVERINE ASSET MANAGEMENT LLC | 2,918,000 | $3,416,000 | 0.03% |
| FRANKLIN RESOURCES INC | 48,000,000 | $56,240,000 | 0.02% |